Alternatively, the suppression of SSA by hRAD52 S346X may block tumor formation in BRCA2‐deficient cells because of their loss of two mechanisms of DSB repair, leading to the increased persistence of DSBs and apoptosis. Here, BRCA2 is linked to neoplasm.